TY - JOUR
T1 - Stakeholder Research Priorities to Promote Implementation of Shared Decision-Making for Lung Cancer Screening An American Thoracic Society and Veterans Affairs Health Services Research and Development Statement
AU - on behalf of the American Thoracic Society and Veterans Affairs Health Services Research and Development
AU - Soylemez Wiener, Renda
AU - Fix, Gemmae M.
AU - Barker, Anna M.
AU - Bokhour, Barbara G.
AU - Carter-Harris, Lisa
AU - Caverly, Tanner J.
AU - Crocker, David A.
AU - Denietolis, Angela
AU - Doherty, Charlotte
AU - Fagerlin, Angela
AU - Lauren, G. A.J.
AU - Gallagher-Seaman, Mary
AU - Gould, Michael K.
AU - Han, Paul K.J.
AU - Herbst, Abigail N.
AU - Ito Fukunaga, Mayuko
AU - Kaitz, Jenesse E.
AU - Kim, Jane
AU - Magee, Shannon
AU - Mazzone, Peter J.
AU - McCullough, Megan B.
AU - Miano, Danielle A.
AU - Nici, Linda
AU - Plant, Larry
AU - Quaife, Samantha L.
AU - Rivera, M. Patricia
AU - Saeed, Aysha
AU - Schapira, Marilyn M.
AU - Slatore, Christopher G.
AU - Tanner, Nichole T.
AU - Thomson, Carey
AU - White, Julie
AU - Yarbrough, William C.
AU - Zeliadt, Steve
N1 - Funding Information:
an advisory committee for CHEST and the National Lung Cancer Round Table; and received research support from the NIH, Patient-Centered Outcomes Research Institute, and the VA Health Services Research & Development Service. G.M.F. is an employee of and received research support from the Department of Veterans Affairs. T.J.C. has a licensed patent for a decision precision tool, which helps with prediction-based shared decision-making and personalizes the screening decision. A.F. received research support from the Department of Veterans Affairs. M.K.G. served on an advisory committee for the President’s Cancer Panel; served on a data safety and monitoring board for the Veterans Health Administration; served as Deputy Editor for Thoracic Oncology and for Annals of the American Thoracic Society; received research support from Medial Earlysign; and received author royalties from UpToDate. A.N.H. received research support from the VA Health Services Research & Development Service. M.I.F. received research support from the NHLBI. P.J.M. received research support from AstraZeneca, Biodesix, DELFI, Exact Sciences, MagArray, Nucleix, PrognomiQ, and Veracyte. M.P.R. served as a consultant for the American Board of Internal Medicine, bioAffinity, Biodesix, and Johnson & Johnson. N.T.T. served as a consultant for Olympus Medical; and received research support from Exact Sciences, Oncimmune, Oncocyte, Nucleix, and SEER. C.T. served on an advisory committee for American College of Radiology and Healthmyne; served as a consultant for Fulcrum; served as a speaker for American Lung Association and National Lung Cancer Roundtable; and received author royalties from UpToDate. A.M.B., B.G.B., L.C.-H., D.A.C., A.D., C.D., L.G., M.G.-S., P.K.J.H., J.E.K., J.K., S.M., M.B.M., D.A.M., L.N., L.P., S.L.Q., A.S., M.M.S., C.G.S., J.W., W.C.Y., and S.Z. reported no commercial or relevant noncommercial interests.
Funding Information:
Supported by Veterans Affairs (VA) Health Services Research and Development (grant RVR 19-491) and the American Thoracic Society, and supported by resources from the VA Boston, VA Bedford, VA Ann Arbor, VA Salt Lake City, and VA Portland Healthcare Systems. A part of M.I.F.’s work was supported by the NHLBI through grant 1K12HK138049-01. G.M.F. is a VA Health Services Research and Development Career Development awardee at the Bedford VA (CDA 14-156). The funding agencies did not have a role in the conduct of the study, in the collection, management, analysis, interpretation of data, or in the preparation of the manuscript. The findings and conclusions in this report are those of the authors, and do not necessarily represent the official positions of the Department of Veterans Affairs, the NIH, or the U.S. government.
Publisher Copyright:
Copyright © 2022 by the American Thoracic Society
PY - 2022/3/15
Y1 - 2022/3/15
N2 - Rationale: Shared decision-making (SDM) for lung cancer screening (LCS) is recommended in guidelines and required by Medicare, yet it is seldom achieved in practice. The best approach for implementing SDM for LCS remains unknown, and the 2021 U.S. Preventive Services Task Force calls for implementation research to increase uptake of SDM for LCS. Objectives: To develop a stakeholder-prioritized research agenda and recommended outcomes to advance implementation of SDM for LCS. Methods: The American Thoracic Society and VA Health Services Research and Development Service convened a multistakeholder committee with expertise in SDM, LCS, patient-centered care, and implementation science. During a virtual State of the Art conference, we reviewed evidence and identified research questions to address barriers to implementing SDM for LCS, as well as outcome constructs, which were refined by writing group members. Our committee (n = 34) then ranked research questions and SDM effectiveness outcomes by perceived importance in an online survey. Results: We present our committee’s consensus on three topics important to implementing SDM for LCS: 1) foundational principles for the best practice of SDM for LCS; 2) stakeholder rankings of 22 implementation research questions; and 3) recommended outcomes, including Proctor’s implementation outcomes and stakeholder rankings of SDM effectiveness outcomes for hybrid implementation–effectiveness studies. Our committee ranked questions that apply innovative implementation approaches to relieve primary care providers of the sole responsibility of SDM for LCS as highest priority. We rated effectiveness constructs that capture the patient experience of SDM as most important. Conclusions: This statement offers a stakeholder-prioritized research agenda and outcomes to advance implementation of SDM for LCS.
AB - Rationale: Shared decision-making (SDM) for lung cancer screening (LCS) is recommended in guidelines and required by Medicare, yet it is seldom achieved in practice. The best approach for implementing SDM for LCS remains unknown, and the 2021 U.S. Preventive Services Task Force calls for implementation research to increase uptake of SDM for LCS. Objectives: To develop a stakeholder-prioritized research agenda and recommended outcomes to advance implementation of SDM for LCS. Methods: The American Thoracic Society and VA Health Services Research and Development Service convened a multistakeholder committee with expertise in SDM, LCS, patient-centered care, and implementation science. During a virtual State of the Art conference, we reviewed evidence and identified research questions to address barriers to implementing SDM for LCS, as well as outcome constructs, which were refined by writing group members. Our committee (n = 34) then ranked research questions and SDM effectiveness outcomes by perceived importance in an online survey. Results: We present our committee’s consensus on three topics important to implementing SDM for LCS: 1) foundational principles for the best practice of SDM for LCS; 2) stakeholder rankings of 22 implementation research questions; and 3) recommended outcomes, including Proctor’s implementation outcomes and stakeholder rankings of SDM effectiveness outcomes for hybrid implementation–effectiveness studies. Our committee ranked questions that apply innovative implementation approaches to relieve primary care providers of the sole responsibility of SDM for LCS as highest priority. We rated effectiveness constructs that capture the patient experience of SDM as most important. Conclusions: This statement offers a stakeholder-prioritized research agenda and outcomes to advance implementation of SDM for LCS.
UR - http://www.scopus.com/inward/record.url?scp=85126702518&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85126702518&partnerID=8YFLogxK
U2 - 10.1164/rccm.202201-0126ST
DO - 10.1164/rccm.202201-0126ST
M3 - Article
C2 - 35289730
AN - SCOPUS:85126702518
SN - 1073-449X
VL - 205
SP - 619
EP - 630
JO - American Review of Respiratory Disease
JF - American Review of Respiratory Disease
IS - 6
ER -